Pathogenesis of Recalcitrant Chronic Rhinosinusitis: The Emerging Role of Innate Immune Cells

키워드

참고문헌 (77)

1. Fokkens WJ, "EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists", Rhinology, 50, pp.1~12 (2012)
2. 김도현, "Effect of Chronic Rhinosinusitis With or Without Nasal Polyp on Quality of Life in South Korea: 5th Korea National Health and Nutrition Examination Survey Korean", Clinical and Experimental Otorhinolaryngology, 9(2), pp.150~156 (2016), 대한이비인후과학회[DOI]
3. Wang X, "Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania", J Allergy Clin Immunol, 138, pp.1344~1353 (2016)[DOI]
4. Blackwell DL, "Summary health statistics for U.S. adults: national health interview survey, 2012", Vital Health Stat, 10, pp.1~161 (2014)
5. Huvenne W, "Chronic rhinosinusitis with and without nasal polyps: what is the difference?", Curr Allergy Asthma Rep, 9, pp.213~220 (2009)[DOI]
6. Kim DW, "The status of the olfactory cleft may predict postoperative olfactory function in chronic rhinosinusitis with nasal polyposis", Am J Rhinol Allergy, 25, pp.e90~e94 (2011)[DOI]
7. Lou H, "Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population", Am J Rhinol Allergy, 29, pp.350~356 (2015)[DOI]
8. Bachert C, "Phenotypes and emerging endotypes of chronic rhinosinusitis", J Allergy Clin Immunol Pract, 4, pp.621~628 (2016)[DOI]
9. Kim DK, "MBP-positive and CD11c-positive cells are associated with different phenotypes of Korean patients with non-asthmatic chronic rhinosinusitis", PLoS One, 9, pp.e111352~ (2014)[DOI]
10. Zhang N, "Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease", J Allergy Clin Immunol, 122, pp.961~968 (2008)[DOI]
11. Mahdavinia M, "Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia", J Allergy Clin Immunol, 135, pp.576~579 (2015)[DOI]
12. Liao B, "Interaction of thymic stromal lymphopoietin, IL-33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps", Allergy, 70, pp.1169~1180 (2015)[DOI]
13. Comeau MR, "The influence of TSLP on the allergic response", Mucosal Immunol, 3, pp.138~147 (2010)[DOI]
14. Kouzaki H, "The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses", J Immunol, 186, pp.4375~4387 (2011)[DOI]
15. Ziegler SF, "Thymic stromal lymphopoietin and allergic disease", J Allergy Clin Immunol, 130, pp.845~852 (2012)[DOI]
16. Cayrol C, "IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy", Curr Opin Immunol, 31, pp.31~37 (2014)[DOI]
17. Licona-Limon P, "TH2, allergy and group 2 innate lymphoid cells", Nat Immunol, 14, pp.536~542 (2013)[DOI]
18. Moussion C, "The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?", PLoS One, 3, pp.e3331~ (2008)[DOI]
19. Pichery M, "Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain", J Immunol, 188, pp.3488~3495 (2012)[DOI]
20. Prefontaine D, "Increased IL-33 expression by epithelial cells in bronchial asthma", J Allergy Clin Immunol, 125, pp.752~754 (2010)[DOI]
21. Byers DE, "Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease", J Clin Invest, 123, pp.3967~3982 (2013)[DOI]
22. Chang YJ, "Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity", Nat Immunol, 12, pp.631~638 (2011)[DOI]
23. Hardman CS, "IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation", Eur J Immunol, 43, pp.488~498 (2013)[DOI]
24. Tjota MY, "IL-33-dependent induction of allergic lung inflammation by <TEX>$Fc{\gamma}RIII$<", TEX> signaling, 2013, pp.123, 2287~2297
25. Luzina IG, "Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion", J Immunol, 189, pp.403~410 (2012)[DOI]
26. Mizutani N, "IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice", J Immunol, 192, pp.1372~1384 (2014)[DOI]
27. Lan F, "Interleukin-33 facilitates neutrophil recruitment and bacterial clearance in S. aureus-caused peritonitis", Mol Immunol, 72, pp.74~80 (2016)[DOI]
28. Shaw JL, "IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps", Am J Respir Crit Care Med, 188, pp.432~439 (2013)[DOI]
29. Miljkovic D, "Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis", Allergy, 69, pp.1154~1161 (2014)[DOI]
30. Lam M, "Clinical severity and epithelial endotypes in chronic rhinosinusitis", Int Forum Allergy Rhinol, 3, pp.121~128 (2013)[DOI]
31. Reh DD, "Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33", Am J Rhinol Allergy, 24, pp.105~109 (2010)[DOI]
32. Baba S, "Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps", Laryngoscope, 124, pp.E115~E122 (2014)[DOI]
33. Kim DK, "The role of interleukin-33 in chronic rhinosinusitis", Thorax, 72, pp.635~645 (2017)[DOI]
34. Godin MS, "Nasal augmentation using Gore-Tex. A 10-year experience", Arch Facial Plast Surg, 1, pp.118~121 (1999)[DOI]
35. Iwakura Y, "Functional specialization of interleukin-17 family members", Immunity, 34, pp.149~162 (2011)[DOI]
36. Fort MM, "IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo", Immunity, 15, pp.985~995 (2001)[DOI]
37. Sharkhuu T, "Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity", Clin Exp Allergy, 36, pp.1575~1583 (2006)[DOI]
38. Corrigan CJ, "Allergeninduced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses", J Allergy Clin Immunol, 128, pp.116~124 (2011)[DOI]
39. Spits H, "Innate lymphoid cells--a proposal for uniform nomenclature", Nat Rev Immunol, 13, pp.145~149 (2013)[DOI]
40. Yokota Y, "Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2", Nature, 397, pp.702~706 (1999)[DOI]
41. Robinette ML, "Immune modules shared by innate lymphoid cells and T cells", J Allergy Clin Immunol, 138, pp.1243~1251 (2016)[DOI]
42. Neill DR, "Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity", Nature, 464, pp.1367~1370 (2010)[DOI]
43. Moro K, "Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells", Nature, 463, pp.540~544 (2010)[DOI]
44. Mjosberg JM, "Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161", Nat Immunol, 12, pp.1055~1062 (2011)[DOI]
45. Mjosberg J, "The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells", Immunity, 37, pp.649~659 (2012)[DOI]
46. Shikotra A, "Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma", J Allergy Clin Immunol, 129, pp.104~111 (2012)[DOI]
47. Morita H, "Innate lymphoid cells in allergic and nonallergic inflammation", J Allergy Clin Immunol, 138, pp.1253~1264 (2016)[DOI]
48. Kim HY, "Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity", J Allergy Clin Immunol, 129, pp.216~227 (2012)[DOI]
49. Ho J, "Cellular comparison of sinus mucosa vs polyp tissue from a single sinus cavity in chronic rhinosinusitis", Int Forum Allergy Rhinol, 5, pp.14~27 (2015)[DOI]
50. Ho J, "Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia", Clin Exp Allergy, 45, pp.394~403 (2015)[DOI]
51. Townley RG, "CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils", Ann Allergy Asthma Immunol, 109, pp.365~374 (2012)[DOI]
52. Xue L, "Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells", J Allergy Clin Immunol, 133, pp.1184~1194 (2014)[DOI]
53. Chang JE, "Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis", J Allergy Clin Immunol, 133, pp.899~901 (2014)[DOI]
54. Kato A, "Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells", J Immunol, 182, pp.7233~7243 (2009)[DOI]
55. Doherty TA, "Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production", J Allergy Clin Immunol, 132, pp.205~213 (2013)[DOI]
56. Takabayashi T, "Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps", J Allergy Clin Immunol, 130, pp.410~420 (2012)[DOI]
57. Petersen BC, "Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology", Nat Med, 18, pp.751~758 (2012)[DOI]
58. Kabata H, "Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation", Nat Commun, 4, pp.2675~ (2013)[DOI]
59. Kim HY, "Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesityassociated airway hyperreactivity", Nat Med, 20, pp.54~61 (2014)[DOI]
60. Gordon S, "Monocyte and macrophage heterogeneity", Nat Rev Immunol, 5, pp.953~964 (2005)[DOI]
61. Geissmann F, "Unravelling mononuclear phagocyte heterogeneity", Nat Rev Immunol, 10, pp.453~460 (2010)[DOI]
62. Murray PJ, "Obstacles and opportunities for understanding macrophage polarization", J Leukoc Biol, 89, pp.557~563 (2011)[DOI]
63. Meng J, "The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling", PLoS One, 8, pp.e82373~ (2013)[DOI]
64. Yamaguchi M, "PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation", J Leukoc Biol, 100, pp.131~141 (2016)[DOI]
65. Yao Y, "Increased expression of TIPE2 in alternatively activated macrophages is associated with eosinophilic inflammation and disease severity in chronic rhinosinusitis with nasal polyps", Int Forum Allergy Rhinol, 7, pp.963~972 (2017)[DOI]
66. Krysko O, "Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis", Allergy, 66, pp.396~403 (2011)[DOI]
67. Takabayashi T, "Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps", J Allergy Clin Immunol, 132, pp.584~592 (2013)[DOI]
68. Van Zele T, "Differentiation of chronic sinus diseases by measurement of inflammatory mediators", Allergy, 61, pp.1280~1289 (2006)[DOI]
69. Cuartero MI, "N2 neutrophils, novel players in brain inflammation after stroke: modulation by the <TEX>$PPAR{\gamma}$<", TEX> agonist rosiglitazone, 2013, pp.44, 3498~3508
70. Ma Y, "Temporal neutrophil polarization following myocardial infarction", Cardiovasc Res, 110, pp.51~61 (2016)[DOI]
71. Pothoven KL, "Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease", J Allergy Clin Immunol, 139, pp.1966~1978 (2017)[DOI]
72. Pothoven KL, "Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease", J Allergy Clin Immunol, 136, pp.737~746 (2015)[DOI]
73. Fokkens WJ, "European position paper on rhinosinusitis and nasal polyps 2012", Rhinol Suppl, 23, pp.3~ (2012)
74. Weathington NM, "A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation", Nat Med, 12, pp.317~323 (2006)[DOI]
75. Snelgrove RJ, "A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation", Science, 330, pp.90~94 (2010)[DOI]
76. Wen W, "Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy", J Allergy Clin Immunol, 129, pp.1522~1528 (2012)[DOI]
77. Cao PP, "Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese", J Allergy Clin Immunol, 124, pp.478~484 (2009)[DOI]

관련 논문AI추천